Haemonetics | Des Atouts



Assets Changement Date
Avanos Medical USD 1.15B 502M 2024-12
Baxter International USD 25.78B 894M 2024-12
Becton, Dickinson and Co. USD 54.47B 198M 2025-03
Boston Scientific USD 40.14B 745M 2025-03
Cooper Companies USD 12.22B 93M 2025-01
Fresenius EUR 43.55B 1.18B 2024-12
Fresenius Medical Care EUR 33.57B 1.06B 2024-12
Globus Medical USD 5.25B 165.71M 2024-12
Haemonetics USD 2.53B 6.05M 2024-12
Hologic USD 8.55B 183.6M 2025-03
ICU Medical USD 4.2B 101.11M 2024-12
Intuitive Surgical USD 19.22B 477.2M 2025-03
Masimo USD 2.63B 462.1M 2024-12
Medtronic USD 89.97B 69M 2025-01
Merit Medical Systems USD 2.47B 49.37M 2025-03
Neogen USD 4.04B 17.76M 2025-02
Quidel USD 6.42B 377.5M 2024-12
ResMed USD 7.57B 425.49M 2025-03
STAAR Surgical USD 509.52M 28.07M 2024-12
Steris USD 10.01B 233.78M 2024-12
Stryker USD 46.01B 3.04B 2025-03
Teleflex USD 7.16B 65.38M 2025-03
Terumo JPY 1.88T 125.37B 2024-12
Thermo Fisher Scientific USD 99.04B 1.72B 2025-03
US Physical Therapy USD 1.17B 138.28M 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Haemonetics Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.